Stock Movers: Apple & Intel Rise on Tariff Pause, Pfizer Dips on Obesity Drug Pivot

Chip Sector Rally on Tariff Exemptions

• 칩 🚀 Intel is leading the chip sector rally, up 4.4% on heavy volume, trading near $21 a share.
• 칩 🚀 Micron is also seeing significant gains, up 4.3% and trading at $72 a share.
• 칩 💡 Many chip-exposed companies like Dell are rallying due to tariff exemptions that include consumer electronics.
• 칩 💡 Apple experienced an initial surge of over 6% in pre-market trading and is now up 4.5%, trading at $27 a share.

Bull and Bear Cases for Tech Stocks

• 🐂 The bull case suggests that lower tariff rates increase the likelihood of companies like Apple digesting costs and pricing accordingly, protecting profit margins.
• 🐂 Apple's iPhone profit margins are noted at 43%, highlighting the impact of tariff rates on profitability.
• 🐻 The bear case posits that current market conditions are not indicative of peak uncertainty and that the situation could worsen.

Pfizer's Obesity Drug Setback

• 💊 Pfizer is experiencing a downturn, down nearly 2% earlier in the session, as they plan to discontinue their obesity drug, danuglipron.
• ⚠️ The company cited safety concerns, specifically a potential drug-related liver injury observed in a clinical trial patient.
• 🎯 Pfizer will now shift focus to earlier-stage obesity treatments, facing challenges in competing with Novo Nordisk and Eli Lilly in the weight-loss market.

Comcast Downgraded by Wells Fargo

• 📉 Comcast shares are down about 1.4%, trading at $33 a share.
• 📉 This decline follows a downgrade from Wells Fargo, which cut the stock to 'underweight' with a price target of $31 a share.